Examining the Effect of Mandala Art Therapy on Symptoms and Quality of
Examining the Effect of Mandala Art Therapy on Symptoms and Quality of Life in Multiple Sclerosis Patients
What it found
No result yet.
What was tested
Treatment tested
- Mandala Art Therapy
What it measured
Main measures
Quality of life of patient with MS
6 week
Quality of life (reported by participants)
Other measures (1)
Symptom evaluation of patient with MS
6 week
Who could take part
MS (type not specified) · 18 to 65
Show the full criteria
Inclusion criteria
* Residing in the city center of Trabzon * Diagnosed with Multiple Sclerosis at least six months prior * Have not experienced an MS relapse within the past three months * Receiving outpatient treatment for MS * Literate * Have no prior experience with mandala practice * Not currently participating in any form of art therapy * Have no communication or perception impairments
Exclusion criteria
* Those who have experienced an MS relapse within the past three months * Those receiving inpatient treatment for MS * Individuals aged 18 years or younger * Those with a physical disability that prevents them from participating in the mandala activity * Individuals currently engaged in any form of active art therapy * Those with communication or perception impairments * Individuals with a diagnosed psychiatric disorder * Those who cannot be reached via phone and/or text message * Individuals with allergies to materials used in the mandala therapy sessions
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This study is a randomized controlled, pre-test-post-test experimental research aimed at examining the effects of mandala art therapy on symptom severity and quality of life in individuals diagnosed with Multiple Sclerosis (MS). The main goal is to determine whether mandala art therapy helps reduce the frequency and severity of MS symptoms while improving participants' overall quality of life. It is expected that mandala art therapy will support MS patients in managing current and potential symptoms, coping more effectively with the disease, and improving adherence to treatment. As a result, a reduction in healthcare utilization, related costs, MS-related complications, and mortality is anticipated. The study will be conducted between May and August 2025 at the Neurology Outpatient Clinic of Karadeniz Technical University Practice and Research Center, involving 70 patients-35 in the intervention group receiving mandala art therapy and 35 in the control group receiving standard care.
Loading reviews and guidelines…
History
Started
May 2025
Main results due
Jul 2025
Finished
Aug 2025